Predict your next investment

Angel Investor (Group)
dukeangelnetwork.duke.edu

See what CB Insights has to offer

Investments

17

Portfolio Exits

4

About Duke Angel Network

The Duke Angel Network (DAN) is uniquely dedicated to connecting, supporting, and cultivating the Duke entrepreneurial community. In addition to providing capital, we actively match Duke alumni expertise with portfolio companies to drive growth.

Duke Angel Network Headquarter Location

140 Science Drive Suite 102

Durham, North Carolina, 27708,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Duke Angel Network News

Biotechnology Startup Xilis Raises $70 mln to Help Develop Personalized Cancer Treatments

Jul 9, 2021

By Nicholas Say Nicholas Say has been verified by Muck Rack's editorial team Xilis, a biotechnology startup based in North Carolina, announced a raise of $70 million in Series A funding on July 8th. The funding round was led by Mubadala Capital and counted with the participation of new investors like GV (formerly Google Ventures), LSP (one of Europe’s largest healthcare investment firms), Catalio Capital Management, and Duke […] / share Published on July 9, 2021 The funding round was led by Mubadala Capital and counted with the participation of new investors like GV (formerly Google Ventures), LSP (one of Europe’s largest healthcare investment firms), Catalio Capital Management, and Duke Angel Network. Prior to the round, existing investors included Felicis Ventures, Two Sigma Ventures, Pear VC, KdT Ventures, and Alix Ventures. By studying the miniature tumor, oncologists can make better decisions when it comes to treating cancer. Xiling Shen, Ph.D., Founder and Chief Executive Officer of Xilis, referred to the startup’s objective and the role investors play in it by stating: “Our vision is to transform cancer care in diagnostics and reshape drug development by providing technology for rapid therapeutic profiling. The support provided by these world-class investors is an important milestone for our journey to transform cancer care and dramatically improve patient survival by enabling personalized precision oncology and bringing transformative medicines to patients faster and with higher success rates.” Xilis was founded back in 2019 by Dr. Xiling Shen, Dr. David Hsu, and Dr. Hans Clevers, combining decades of experience in biomedical, oncology, and stem cell research. Dr. Clevers, who has been the winner of several prizes in the field of medicine, was the inventor of organoids more than 10 years ago. According to a statement, proceeds from the funding round will go to further advance Xilis’ MOS technology, expand its Artificial Intelligence-driven capabilities, fund clinical studies for diagnostic development, and partner with biopharma companies to validate the use of MOS. The biotechnology startup believes that its technology can help patients avoid the drawbacks of unnecessary oncology treatments by facilitating the diagnosis and planning of the best treatment for each case. Tags

Duke Angel Network Investments

17 Investments

Duke Angel Network has made 17 investments. Their latest investment was in Sparta Biomedical as part of their Seed on December 12, 2021.

CBI Logo

Duke Angel Network Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

12/14/2021

Seed

Sparta Biomedical

$5M

Yes

Nanosha, and Undisclosed Angel Investors

4

7/8/2021

Series A

Xilis

$70M

Yes

22

6/3/2021

Series A - II

Realtime Robotics

$20M

No

3

10/13/2020

Seed VC - II

Subscribe to see more

$99M

Subscribe to see more

10

4/9/2020

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

12/14/2021

7/8/2021

6/3/2021

10/13/2020

4/9/2020

Round

Seed

Series A

Series A - II

Seed VC - II

Series A

Company

Sparta Biomedical

Xilis

Realtime Robotics

Subscribe to see more

Subscribe to see more

Amount

$5M

$70M

$20M

$99M

$99M

New?

Yes

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Nanosha, and Undisclosed Angel Investors

Sources

4

22

3

10

10

Duke Angel Network Portfolio Exits

4 Portfolio Exits

Duke Angel Network has 4 portfolio exits. Their latest portfolio exit was SaaSOptics on April 13, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

4/13/2022

Merger

$99M

2

4/27/2020

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

9/4/2018

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

9/7/2017

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/13/2022

4/27/2020

9/4/2018

9/7/2017

Exit

Merger

Acquired

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

10

10

10

Duke Angel Network Team

2 Team Members

Duke Angel Network has 2 team members, including former Managing Director, John Glushik.

Name

Work History

Title

Status

John Glushik

Managing Director

Former

John Glushik

Managing Director

Former

Name

John Glushik

John Glushik

Work History

Title

Managing Director

Managing Director

Status

Former

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.